Literature DB >> 11550121

Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains.

P M van Tilburg1, D Bogaert, M Sluijter, A R Jansz, R de Groot, P W Hermans.   

Abstract

A multidrug-resistant strain of Streptococcus pneumoniae was isolated in The Netherlands during a nosocomial outbreak among 36 patients who mainly had chronic obstructive pulmonary disease. After the commencement of barrier nursing and short-term ceftriaxone-rifampin eradication therapy, the epidemic ceased. However, eradication therapy failed in 3 patients, and follow-up investigation of these patients showed the emergence of rifampin-resistant isolates.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11550121     DOI： 10.1086/323021

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

1.  African Tick Bite Fever Treated Successfully With Rifampin in a Patient With Doxycycline Intolerance.

Authors:  Andrew Strand; Christopher D Paddock; Alex R Rinehart; Marah E Condit; Jessica R Marus; Shezeen Gillani; Ida H Chung; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

2.  New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.

Authors:  María José Ferrándiz; Carmen Ardanuy; Josefina Liñares; José María García-Arenzana; Emilia Cercenado; Ana Fleites; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Low-level resistance to rifampin in Streptococcus pneumoniae.

Authors:  Patricia Stutzmann Meier; Silvia Utz; Suzanne Aebi; Kathrin Mühlemann
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  Evaluation of meropenem alone and combined with rifampin in the guinea pig model of pneumococcal meningitis.

Authors:  E Force; F Taberner; C Cabellos; S Ribes; A Doménech; F Tubau; P F Viladrich; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-17       Impact factor: 3.267

Review 5.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.